# Pharmacokinetic Drug-drug Interaction of CKD-330 and D086

> **NCT03017950** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 83 (actual)

## Conditions studied

- Hypertension
- Hyperlipidemias

## Interventions

- **DRUG:** CKD-330
- **DRUG:** D086
- **DRUG:** CKD-330 + D086

## Key facts

- **NCT ID:** NCT03017950
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2017-03
- **Final completion:** 2017-05
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2017-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03017950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03017950, "Pharmacokinetic Drug-drug Interaction of CKD-330 and D086". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03017950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*